Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution

Journal of Pharmaceutical and Biomedical Analysis

Volumn 52, Issue 1, 2010, Pages 19-29

  Kasawar, Gajanan B ^a   Farooqui, Mazahar ^a  

^a MAULANA AZAD COLLEGE   (India)

Author keywords

Albuterol sulfate; Development; Ipratropium bromide; Related substance; RP HPLC; Stability indicating method; Validation

Indexed keywords

ACETONITRILE; HEPTANE; IPRATROPIUM BROMIDE; PHOSPHORIC ACID; POTASSIUM DIHYDROGEN PHOSPHATE; SALBUTAMOL SULFATE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DIODE; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG IMPURITY; DRUG STABILITY; DRUG STRUCTURE; ELUTION; FLOW RATE; HYDROLYSIS; OXIDATION; PH; PHOTOLYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; TEMPERATURE;

ADMINISTRATION, INTRANASAL; ALBUTEROL; BRONCHODILATOR AGENTS; BUFFERS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; DRUG CONTAMINATION; DRUG STABILITY; GUIDELINES AS TOPIC; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; IPRATROPIUM; KINETICS; OXIDATION-REDUCTION; PHARMACEUTICAL SOLUTIONS; PHOTOLYSIS; REPRODUCIBILITY OF RESULTS; SOLVENTS; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 74449087902     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.11.026     Document Type: Article

References (31)

1. Reinero C.R., Delgado C., Spinka C., Declue A.E., and Dhand R. Enantiomer-specific effects of albuterol on airway inflammation in healthy and asthmatic cats. Int. Arch. Allergy Immunol. 150 (2009) 43-50
2. Baigelman W., and Chodosh S. Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000) as an aerosol in chronic bronchitis and asthma. Chest 71 (1977) 324-328
3. Magardino T.M., Suskind-Liu D., Kroger H., and Mirza N. Ipratropium bromide nasal spray for treatment of rhinorrhea in the laryngectomized patient: a pilot study. Am. J. Rhinol. 15 (2001) 203-206
4. Gelb A.F., Karpel J., Wise R.A., Cassino C., Johnson P., and Conoscenti C.S. Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma. Pulm. Pharmacol. Ther. 21 (2008) 630-636
5. United State Pharmacopeia, 28th ed., National Formulary, 23rd ed., 57; Pharmacopeial forum, Albuterol sulfate, 27 (3) 2506.
6. European Pharmacopoeia, Ipratropium bromide, 6th ed., Strasbourg, 2006, p. 2855.
7. Agostini O., Chiari A., and Baffoni D.C. Simultaneous high-performance liquid chromatographic determination of salbutamol sulphate, theophylline, and saccharin in a hydroalcoholic formulation. Boll. Chim. Farm. 121 (1982) 612-618
8. Erram S.V., Fanska C.B., and Asif M. Determination of albuterol sulfate and its related substances in albuterol sulfate inhalation solution, 0.5% by RP-HPLC. J. Pharm. Biomed. Anal. 40 (2006) 864-874
9. Malkki L., and Tammilehto S. Optimization of the separation of salbutamol and its decomposition products by liquid chromatography with diode-array detection. J. Pharm. Biomed. Anal. 11 (1993) 79-84
10. Beaulieu N., Cyr T.D., and Lovering E.G. Liquid chromatographic methods for the determination of albuterol (salbutamol), albuterol sulphate and related compounds in drug raw materials, tablets and inhalers. J. Pharm. Biomed. Anal. 8 (1990) 583-589
11. Ong H., Adam A., Perreault S., Marleau S., Bellemare M., Du Souich P., and Beaulieu N. Analysis of albuterol in human plasma based on immunoaffinity chromatographic clean-up combined with high-performance liquid chromatography with fluorimetric detection. J. Chromatogr. 497 (1989) 213-221
12. Halabi A., Ferrayoli C., Palacio M., Dabbene V., and Palacios S. Validation of a chiral HPLC assay for (R)-salbutamol sulfate. J. Pharm. Biomed. Anal. 34 (2004) 45-51
13. Rogan M.M., Altria K.D., and Goodall D.M. Enantiomeric separation of salbutamol and related impurities using capillary electrophoresis. Electrophoresis 15 (1994) 808-817
14. Zhang J., Xu Y., Di X., and Wu M. Quantitation of salbutamol in human urine by liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 831 (2006) 328-332
15. Weisberger M., Patrick J.E., and Powell M.L. Quantitative analysis of albuterol in human plasma by combined gas chromatography chemical ionization mass spectrometry. Biomed. Mass Spectrom. 10 (1983) 556-558
16. Jacobson G.A., and Peterson G.M. High-performance liquid chromatographic assay for the simultaneous determination of ipratropium bromide, fenoterol, salbutamol and terbutaline in nebulizer solution. J. Pharm. Biomed. Anal. 12 (1994) 825-832
17. Simms P.J., Towne R.W., Gross C.S., and Miller R.E. The separation of ipratropium bromide and its related compounds. J. Pharm. Biomed. Anal. 17 (1998) 841-849
18. Hassan E.M. Determination of ipratropium bromide in vials using kinetic and first-derivative spectrophotometric methods. J. Pharm. Biomed. Anal. 21 (2000) 1183-1189
19. FDA. Guidance for Industry, Analytical Procedures and Method Validation (Chemistry, Manufacturing and Controls Documentation) (2000), Center for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), Rockville, USA
20. Bakshi M., and Singh S. Development of validated stability-indicating assay methods-critical review. J. Pharm. Biomed. Anal. 28 (2002) 1011-1040
21. Swartz M., and Krull I. Analytical method validation for biotechnology proteins, peptides, and antibodies. LC GC 23 (2005) 586-593
22. International Conference on Harmonization (ICH) Q1A (R2): Stability Testing of New Drug Substances and Products. USA (2003)
23. International Conference on Harmonization (ICH) Q1B, Stability Testing; Photostability Testing of New Drug Substances and Products. USA (1996)
24. International Conference on Harmonization (ICH) Q2 (R1): Validation of Analytical Procedures-Test and Methodology. Geneva, Switzerland (2005)
25. The United State Pharmacopeia. 30th ed. (2007), United State Pharmacopeia Convention, System Suitability Testing, Rockville, USA
26. British Pharmacopeia (2007), Her Majesty's Stationary Office, System Suitability Testing, London, UK
27. Gorenstein M.V., Li J.B., van Antwerp J., and Chapman D. Detecting coeluted impurities by spectral comparison. LC GC 12 (1994) 768-772
28. Young P.M., and Gorenstein M.V. Tryptic mapping by reversed-phase HPLC with photodiode-array detection incorporating the spectral-contrast technique. LC GC 12 (1994) 832-838
29. Warren W.J., Stanick W.A., Gorenstein M.V., and Young P.M. HPLC analysis of synthetic oligonucleotides using spectral contrast techniques. Biotechniques 18 (1995) 282-287
30. FDA. Reviewer Guidance: Validation of Chromatographic Methods (1994), Center for Drug Evaluation Research (CDER), Washington, USA
31. Epshtein N.A. Validation of HPLC techniques for pharmaceutical analysis. Pharm. Chem. J. 38 (2004) 212-228